Honeywell International Inc. (HON) Management presents at Jefferies Industrials Conference (Transcript)
2024-09-05 21:42
Honeywell International Inc. (NASDAQ:HON) Jefferies Industrials Conference September 5, 2024 8:05 AM ET Company Participants Jim Currier - President & CEO, Aerospace Technologies Conference Call Participants Sheila Kahyaoglu - Jefferies Sheila Kahyaoglu Good morning, everyone. My name is Sheila Kahyaoglu, the Jefferies Aerospace, Defense and Airlines Equity Research team. Thank you so much for joining us at our conference and for the Honeywell team to be joining us, always the first slot. We really apprecia ...
Regeneron Pharmaceuticals, Inc. (REGN) Wells Fargo 2024 Healthcare Conference (Transcript)
2024-09-05 21:17
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Wells Fargo 2024 Healthcare Conference September 5, 2024 12:45 PM ET Company Participants Marion McCourt - EVP, Commercial Ryan Crowe - SVP, IR and Strategic Analysis Conference Call Participants Mohit Bansal - Wells Fargo Mohit Bansal Great. So my name is Mohit Bansal, and thank you for the post lunch session. So we will try to keep it exciting, just for the post lunch session. But thank you very much team Regeneron for joining us today. So we have Marion McCou ...
Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
2024-09-05 20:25
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) Morgan Stanley Conference Call September 5, 2024 11:30 AM ET Company Participants Reshma Kewalramani - President and CEO Charlie Wagner - CFO Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclos ...
Sony Group Corporation (SONY) Bank of America's 2024 Media, Communications and Entertainment Conference (Transcript)
2024-09-05 20:23
Sony Group Corporation (NYSE:SONY) Bank of America's 2024 Media, Communications and Entertainment Conference September 5, 2024 11:20 AM ET Company Participants Tony Vinciquerra - Chairman and CEO Unidentified Company Representative Again, we have Tony Vinciquerra, Chairman and CEO, and of Sony Pictures Entertainment. And Tony, you're like -- I don't know, like the industry guru at this point. I would say... Tony Vinciquerra Doesn't take a lot. By the way, it's nice to have Saratoga, my hometown Saratoga. Qu ...
Tyson Foods, Inc. (TSN) Barclays Global Consumer Staples Conference - (Transcript)
2024-09-05 20:17
Tyson Foods, Inc. (NYSE:TSN) Barclays Global Consumer Staples Conference Call September 5, 2024 12:45 PM ET Company Participants Curt Calaway - Chief Financial Officer Brady Stewart - President, Beef and Pork & Chief Supply Chain Officer Conference Call Participants Benjamin Theurer - Barclays Benjamin Theurer All right. Well, good afternoon. Hope lunch was good. Next on stage, we've got Tyson Foods with us, one of the world's largest protein companies with major operations here in the US. Very pleased to h ...
Alcoa Corporation (AA) Presents at Jefferies Global Industrial Conference Call (Transcript)
2024-09-05 20:04
Alcoa Corporation (NYSE:AA) Jefferies Global Industrial Conference Call September 5, 2024 1:20 PM ET Company Participants Molly Beerman - Executive Vice President and Chief Financial Officer Conference Call Participants Christopher LaFemina - Jefferies Christopher LaFemina All right. Thank you all for attending this session. It's my pleasure to host Molly Beerman, who is the CFO at Alcoa and it's going to be a fireside chat format between me and Molly, but we're going to give you an opportunity to ask some ...
Comcast Corporation (CMCSA) Citi's 2024 Global TMT Conference
2024-09-05 20:01
Comcast Corporation (NASDAQ:CMCSA) Citi's 2024 Global TMT Conference September 5, 2024 8:20 AM ET Company Participants Jason Armstrong - CFO Conference Call Participants Michael Rollins - Citi Michael Rollins The clients only and disclosures are available at the back of the room next to the AV desk. Welcome back to Citi's 2024 Global TMT Conference. I'm Mike Rollins with Citi Research, and we're pleased to welcome Jason Armstrong, Chief Financial Officer of Comcast. Jason, thank you for joining us today. Ja ...
Automatic Data Processing, Inc. (ADP) Citi's 2024 Global TMT Conference (Transcript)
2024-09-05 19:53
Automatic Data Processing, Inc. (NASDAQ:ADP) Citi's 2024 Global TMT Conference September 5, 2024 10:50 AM ET Company Participants Joe DeSilva - Executive Vice President, Global Sales Conference Call Participants Peter Christiansen - Citi Investment Research Peter Christiansen Good morning, everyone. My name is Pete Christiansen. I'm with Citi's Equity Research Department covering info services, HR, HCM services, fintech and crypto all have been everywhere here. But great to have Joe DeSilva here. EVP of Glo ...
Intuitive Surgical, Inc. (ISRG) Wells Fargo 2024 Healthcare Conference (Transcript)
2024-09-05 19:52
Summary of Intuitive Surgical, Inc. (NASDAQ:ISRG) Conference Call Company Overview - **Company**: Intuitive Surgical, Inc. - **Event**: Wells Fargo 2024 Healthcare Conference - **Date**: September 5, 2024 - **Participants**: Jamie Samath (CFO), Brandon Lamm (Investor Relations), Larry Biegelsen (Medical Device Analyst, Wells Fargo) Key Points Industry and Market Dynamics - **Market Performance**: In Q2, Intuitive Surgical placed 341 systems globally, representing an 18% increase year-over-year, with 70 of those being da Vinci 5 systems in the U.S. [11][12] - **European Market**: System placements in Europe were lower than the previous year due to government health budget pressures, particularly in Germany and the U.K. [12] - **China Market**: The company noted a dynamic environment in China, with placements affected by anti-corruption initiatives and increased domestic competition. [29][30] Product Launch and Technology - **da Vinci 5 System**: The da Vinci 5 system has received positive feedback from experienced surgeons, particularly regarding its integration, autonomy, and new technologies like Force Feedback and Case Insights. [3][16] - **Future Upgrades**: Planned software and hardware upgrades include integrating Hub technology into the Vision Tower and enhancing the surgeon console with skill simulator capabilities. [7][8] - **Trade-in Strategy**: The company plans to start accepting trade-ins for da Vinci 5 around mid-2025, allowing customers to evaluate their programs based on economic benefits. [14] Financial Performance - **Gross Margin**: Q2 gross margin was reported at 70%, exceeding expectations, but is projected to decrease in the second half of 2024 due to increased depreciation expenses and a shift in revenue mix towards new products with lower margins. [42][44] - **ASP Trends**: Average Selling Prices (ASPs) were up about 4% year-over-year, but future ASP increases may be affected by the mix of outright purchases versus leases. [22][24] Operational Insights - **Utilization Rates**: Utilization growth was about 2% in the first half of the year, lower than historical averages, but expected to normalize as procedure comparisons stabilize. [36] - **Procedure Growth**: The company raised the bottom end of its guidance range for procedure growth based on strong performance in the first half of the year, despite uncertainties in bariatric procedures and the China market. [38] Competitive Landscape - **Competition in Europe and Asia**: The competitive environment remains stable outside of China, where local manufacturers are increasing their presence. Intuitive Surgical maintains a high win ratio in tenders in Europe and Japan. [78][79] - **Local Manufacturing in China**: The company has begun local manufacturing in China to meet tender requirements for domestically produced systems. [81] Future Outlook - **Strategic Focus**: The company aims to prioritize R&D to capitalize on growth opportunities in robotics and computer-assisted interventions. [61] - **Long-term Margin Goals**: Intuitive Surgical aspires to achieve gross margins of 70% over the next 3 to 5 years, with trade-ins from the da Vinci 5 launch expected to contribute positively to margins in the long term. [64][68] Additional Considerations - **Bariatric Procedures**: The company is monitoring the stabilization of bariatric procedures, which have seen a decline, and anticipates potential recovery if physician strikes in Korea resolve. [39][49] - **CapEx and Depreciation**: Significant CapEx spending is expected to lead to increased depreciation expenses, impacting gross margins in the near term. [54][56] This summary encapsulates the key insights and data points discussed during the conference call, providing a comprehensive overview of Intuitive Surgical's current position and future outlook in the healthcare market.
Manulife Financial Corporation (MFC) Presents at 25th Scotiabank Financials Summit Conference (Transcript)
2024-09-05 19:47
Start Time: 13:30 January 1, 0000 2:00 PM ET Manulife Financial Corporation (NYSE:MFC) 25th Scotiabank Financials Summit Conference September 05, 2024, 13:30 AM ET Company Participants Roy Gori - President and CEO Conference Call Participants Meny Grauman - Scotiabank Operator Meny Grauman Hello, again. It's my pleasure to close out the Lifeco portion of the day with Roy Gori, President and CEO of Manulife. Roy Gori Good to see you, Roy. Meny Grauman Good to see you as well. Roy Gori I think the last time ...